Abstract:The mechanism of neuronal loss in Alzheimer's disease (AD) remains unknown, although circumstantial evidence of apoptosis in postmortem brain tissues has supported the hypothesis that an apoptotic mechanism plays a role in the neurodegeneration in AD. Mutations in presenilins 1 and 2 (PS1/2) are responsible for the majority of familial AD. These proteins are localized predominantly in the endoplasmic reticulum (ER) and Golgi apparatus, and form heteromeric protein complexes to participate in several functions. Previous studies have shown that PS1/2 are involved in the regulation of apoptotic cell death, although the molecular basis is still unresolved. The aim of this study is to clarify the molecular basis by which PS1/2 regulate apoptosis. We also address a question how presenilin mutations modify the regulatory activity. We performed yeast 2–hybrid screen, co–immunoprecipitation assay, glycerol velocity gradient centrifugation and subcellular fractionation with iodixanol gradient, using HEK293 cells, PS1/2–knockout mouse fibroblasts and I213T–PS1–knockin mouse brains. PS1/2 interacted with FKBP38 that is an immunophilin family member residing in the mitochondrial membrane and inhibits apoptosis by targeting and anchoring anti–apoptotic Bcl–2 to the mitochondria. PS1/2 and FKBP38 formed macromolecular complexes together with Bcl–2. This complex formation promoted the degradation of FKBP38 and Bcl–2, and sequestered these proteins in the ER/Golgi compartments, thereby inhibiting FKBP38–mediated mitochondrial targeting of Bcl–2. Thus, full–length PS1/2 increased the susceptibility to apoptosis by antagonizing the anti–apoptotic function of FKBP38. In contrast, C–terminal fragments of caspase–processed PS1/2 redistributed Bcl–2 to the mitochondria by abrogating the activity of full–length PS1/2, resulting in a dominant–negative anti–apoptotic effect. In cultured cells and mutant PS1–knockin mouse brains, familial AD–linked PS1/2 mutants enhanced the pro–apoptotic activity by causing a more efficient reduction in mitochondrial Bcl–2 than wild–type PS1/2. We demonstrated that PS1/2 regulate the susceptibility to apoptosis by interacting with FKBP38. These results suggest a novel molecular mechanism for the regulation of mitochondria–mediated apoptosis by competition between PS1/2 and FKBP38 for subcellular targeting of Bcl–2. Furthermore, familial AD–linked mutations in PS1/2 could lower the threshold for activation of mitochondria–mediated apoptosis pathways in neurons of individuals with familial AD.

Substitution of a Glycogen Synthase Kinase-3β Phosphorylation Site in Presenilin 1 Separates Presenilin Function from β-Catenin Signaling*

Phosphorylated Presenilin 1 decreases β-amyloid by facilitating autophagosome-lysosome fusion

Mutation Analysis of Presenilin-1 Gene in Alzheimer' S Disease Patients and the Effects of Its Mutation on Expression of Presenilin-1 and Amyloid Precursor Protein

Random Mutagenesis of Presenilin-1 Identifies Novel Mutants Exclusively Generating Long Amyloid β-Peptides

Quantifying correlations between mutational sites in the catalytic subunit of γ-secretase

APP Substitutions V715F and L720P Alter PS1 Conformation and Differentially Affect Abeta and AICD Generation.

Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.

Presenilin-1, mutated in familial Alzheimer's disease, maintains genome stability via a γ-secretase dependent way

Pathological and Physiological Functions of Presenilins

Presenilin 1 Regulates Pharmacologically Distinct Gamma -Secretase Activities. Implications for the Role of Presenilin in Gamma -Secretase Cleavage.

Interaction of Presenilins with FKBP38 Promotes Apoptosis by Reducing Mitochondrial Bcl-2.

Presenilin-Mediated Modulation of Capacitative Calcium Entry

Familial Alzheimer Disease-linked Presenilin 1 Variants Enhance Production of Both Aβ1–40 and Aβ1–42 Peptides That Are Only Partially Sensitive to a Potent Aspartyl Protease Transition State Inhibitor of “Γ-Secretase”

Presenilin-1 Mutation L271V Results in Altered Exon 8 Splicing and Alzheimer's Disease with Non-cored Plaques and No Neuritic Dystrophy

Presenilin 1 Mutations Linked to Familial Alzheimer's Disease Increase the Intracellular Levels of Amyloid Β‐protein 1–42 and Its N‐Terminally Truncated Variant(s) Which Are Generated at Distinct Sites

Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio in Vitro and in Vivo

Presenilin Deficiency Results in Cellular Cholesterol Accumulation by Impairment of Protein Glycosylation and NPC1 Function

Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice.

FAD-linked Mutations in Presenilin 1 Alter the Length of Abeta Peptides Derived from Betaapp Transmembrane Domain Mutants.

Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1

P3-402: Pathogenic Mutations of Presenilins Enhance Pro-Apoptotic Activity by Reducing Mitochondrial Bcl-2